New Developments in the Management of Non-Small-Cell Lung Cancer, Focus on Rociletinib: What Went Wrong?
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s97644
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2016
Authors
Publisher
Informa UK Limited